Risk of Obstructive Sleep Apnea Assessment Among Patients With Type 2 Diabetes in Taif, Saudi Arabia
| Autor: | Abdulmohsen Hamad Alhamyani, Ibtesam Mohammad Alosaimi, Faisal Adel Alsuqati, Abrar Abdullah Al-ghamdi, Abdulrahman Ahmad Alzahrani, Lojain Abdulaziz Al-shehri, Salwa Ibrahim Abbas, Sultanh Abdullah Alzhrani, Afnan Mohammed Noor Kalakattawi, Abdulaziz Hamad Alhamyani, Reem Mohammed Noor Kalakattawi |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment Population Saudi Arabia 030209 endocrinology & metabolism Disease Type 2 diabetes 03 medical and health sciences 0302 clinical medicine Internal medicine Diabetes mellitus medicine 030212 general & internal medicine education education.field_of_study Oral hypoglycemic business.industry Insulin Diabetes General Medicine medicine.disease Obstructive sleep apnea Obesity Physical therapy Original Article business |
| Zdroj: | Journal of Clinical Medicine Research |
| ISSN: | 1918-3011 1918-3003 |
| DOI: | 10.14740/jocmr3189w |
| Popis: | Background: Obstructive sleep apnea (OSA) is a common condition in middle-aged persons worldwide. The major factor risk of this disease is obesity. Methods: A cross-sectional study was performed at King Abdul-Aziz Specialist Hospital. A STOP-BANG questionnaire formed of eight questions was used to assess the risk of OSA among type 2 diabetic patients. The scoring scale is categorized into three groups: low (0 - 2), intermediate (3 - 4) and high (5 - 8), respectively. By this study, we aimed to assess the risk of OSA among diabetes patients in Taif city. Results: Of the patients, 57.9% had mild risk, 26.9% had moderate risk and 15.2% had severe risk for OSA. There was a moderate positive relationship between age and STOP-BANG score. There was no significant correlation between the score and last fasting blood sugar and HbA1c’s level, with P values of 0.554 and 0.335, respectively. There was a significant relationship between the type of treatment and the risk of developing OSA (P < 0.001). Percentage of patients with severe risk was significantly higher in those taking both insulin and oral drugs than those taking insulin alone or oral drugs alone. Conclusions: The OSA risk and prevalence is much higher in diabetics than in general population, with the risk increasing with age. The risk is higher in diabetic patients who are receiving both oral hypoglycemic drugs and insulin. The screening of OSA among diabetic patients is necessary to identify those at severe risk and manage this problem, which may remain undiagnosed in many patients. J Clin Med Res. 2017;9(12):1002-1006 doi: https://doi.org/10.14740/jocmr3189w |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|